Benralizumab

ATC R03DX10 · 10 markets · 21 records

Benralizumab 10 markets · 21 records Forms

US 4 records · 2 strengths

  • 30 mginjectionFASENRA also in AU·ES·TW
  • 10 mg/0.5 mLinjectionFASENRAManufacturer: Catalent Indiana, LLC

AU 4 records · 3 strengths

  • 30 mginjectionFASENRA benralizumab 30 mg in 1 mL solution for injection prefilled syringeFASENRA PEN benralizumab 30 mg in 1 mL solution for injection prefilled pen also in US·ES·TW unknown
  • 30 mg/1 mLinjectionFasenra Pen also in GB

Records without a stated strength · 1 Fasenra Pen

GB 2 records · 1 strengths

  • 30 mg/1 mLinjectionFasenra 30mg/1ml solution for injection pre-filled pensFasenra 30mg/1ml solution for injection pre-filled syringes also in AU

CA 2 records · 1 strengths

SG 2 records · 1 strengths

  • 30 mg/mLinjectionFASENRA SOLUTION FOR INJECTION 30MG/ML (AUTOINJECTOR PEN)FASENRA SOLUTION FOR INJECTION 30MG/ML (PRE-FILLED SYRINGE)

ES 2 records · 1 strengths

HK 2 records · 1 strengths

    Records without a stated strength · 1 FASENRA SOLUTION FOR INJECTION IN PRE-FILLED PEN 30MG/1ML、FASENRA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30MG/1ML

    TW 1 records · 1 strengths

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 FASENRA

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.